THEALLURION SWALLOWABLE CAPSULE, BACKED BY THE COMPREHENSIVE ALLURION PROGRAM

Allurion, a company dedi- cated to ending obesity,has launche the Allurion Swallowable Capsule in India the only medical weight-loss device fully approved by the Central Drugs Standard  Control Organisation (CDSCO),  the national regulatory authority of India overseen by the Ministry of Health & Family Welfare's Directorate General of Health Services. Dr. Shan-tanu Gaur founded Al-lurion with one goal: end obesity. After completing his undergraduate studies at Harvard University, Dr. Gaur founded the com- pany while completing his medical studies at Harvard Medical School in 2009. Together with his partner and former Harvard professor Dr. Ram Chuttani, IRA he developed the vision for the Allurion Program. At the core of the Allurion Program is the Allurion Swallowable Capsule: the world's first and only swal- lowable, procedureless,
gastric balloon for weight loss. The Allurion Swallowable Capsule is paired with the Allurion Virtual Care Suite, a remote patient monitoring solution pow- ered by the Allurion Iris AI platform that includes the Allurion Mobile App, Connected Scale and
Health Tracker. Tack- ling obesity in India The recent National Family Health Survey (2019-21) found that obesity in India has increased from 21% to 24% among women and 19% to 23% among men between 2016 and 2021. Unhealthy food habits,increasingly sedentary lifestyles and a lack of safe and effective treatments all have contributed to an increase in obesity, which can lead to serious conse- quences such as diabetes and heart disease.